Display options
Cite
Mogensen UM, Jensen T, Køber L, et al. Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes. 2012;61(7):1822-30doi: 10.2337/db11-1235.
Mogensen, U. M., Jensen, T., Køber, L., Kelbæk, H., Mathiesen, A. S., Dixen, U., Rossing, P., Hilsted, J., & Kofoed, K. F. (2012). Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes, 61(7), 1822-30. https://doi.org/10.2337/db11-1235
Mogensen, Ulrik Madvig, et al. "Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients." Diabetes vol. 61,7 (2012): 1822-30. doi: https://doi.org/10.2337/db11-1235
Mogensen UM, Jensen T, Køber L, Kelbæk H, Mathiesen AS, Dixen U, Rossing P, Hilsted J, Kofoed KF. Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients. Diabetes. 2012 Jul;61(7):1822-30. doi: 10.2337/db11-1235. Epub 2012 Apr 12. PMID: 22498696; PMCID: PMC3379682.
Copy Download .nbib Format: NLM
Share it on

Diabetes. 2012 Jul;61(7):1822-30. doi: 10.2337/db11-1235. Epub 2012 Apr 12.

Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients.

Diabetes

Ulrik Madvig Mogensen, Tonny Jensen, Lars Køber, Henning Kelbæk, Anne Sophie Mathiesen, Ulrik Dixen, Peter Rossing, Jannik Hilsted, Klaus Fuglsang Kofoed

Affiliations

  1. The Heart Centre, Department of Cardiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark. [email protected]

PMID: 22498696 PMCID: PMC3379682 DOI: 10.2337/db11-1235

Abstract

Cardiovascular autonomic neuropathy (CAN) is associated with increased mortality in diabetes. Since CAN often develops in parallel with diabetic nephropathy as a confounder, we aimed to investigate the isolated impact of CAN on cardiovascular disease in normoalbuminuric patients. Fifty-six normoalbuminuric, type 1 diabetic patients were divided into 26 with (+) and 30 without (-) CAN according to tests of their autonomic nerve function. Coronary artery plaque burden and coronary artery calcium score (CACS) were evaluated using computed tomography. Left ventricular function was evaluated using echocardiography. Blood pressure and electrocardiography were recorded through 24 h to evaluate nocturnal drop in blood pressure (dipping) and pulse pressure. In patients +CAN compared with -CAN, the CACS was higher, and only patients +CAN had a CACS >400. A trend toward a higher prevalence of coronary plaques and flow-limiting stenosis in patients +CAN was nonsignificant. In patients +CAN, left ventricular function was decreased in both diastole and systole, nondipping was more prevalent, and pulse pressure was increased compared with -CAN. In multivariable analysis, CAN was independently associated with increased CACS, subclinical left ventricular dysfunction, and increased pulse pressure. In conclusion, CAN in normoalbuminuric type 1 diabetic patients is associated with distinct signs of subclinical cardiovascular disease.

References

  1. Diabetes Care. 2003 Jun;26(6):1895-901 - PubMed
  2. Diabet Med. 2000 May;17(5):360-4 - PubMed
  3. Circulation. 2005 Jun 28;111(25):3489-93 - PubMed
  4. Diabetes Res Clin Pract. 1996 Oct;34 Suppl:S165-71 - PubMed
  5. Diabetes Metab Rev. 1994 Dec;10(4):339-83 - PubMed
  6. J Cardiovasc Comput Tomogr. 2010 Nov-Dec;4(6):407.e1-33 - PubMed
  7. Int J Cardiovasc Imaging. 2011 Mar;27(3):413-20 - PubMed
  8. Diabetes Care. 2003 May;26(5):1553-79 - PubMed
  9. Diabetes Metab Res Rev. 2011 Oct;27(7):654-64 - PubMed
  10. Diabetologia. 2001 Feb;44(2):259-66 - PubMed
  11. Arch Pathol Lab Med. 2008 Jan;132(1):43-7 - PubMed
  12. J Am Coll Cardiol. 1998 Jan;31(1):126-33 - PubMed
  13. J Am Coll Cardiol. 2007 Jan 23;49(3):378-402 - PubMed
  14. Diabetologia. 2009 Dec;52(12):2478-88 - PubMed
  15. Circulation. 2004 Aug 31;110(9):1076-82 - PubMed
  16. Diabetes Metab Res Rev. 2011 Oct;27(7):639-53 - PubMed
  17. Diabetes Care. 2010 Mar;33(3):652-7 - PubMed
  18. Endocr J. 2010;57(5):445-54 - PubMed
  19. Diabetes Technol Ther. 2010 Dec;12(12):963-9 - PubMed
  20. J Am Coll Cardiol. 2003 Mar 5;41(5):820-6 - PubMed
  21. J Hypertens. 2002 Sep;20(9):1743-51 - PubMed
  22. Am J Cardiol. 2009 Jan 1;103(1):59-63 - PubMed
  23. J Am Coll Cardiol. 2004 May 5;43(9):1663-9 - PubMed
  24. Lancet. 2008 May 24;371(9626):1790-9 - PubMed
  25. Diabetes Care. 2001 Jun;24(6):1108-14 - PubMed
  26. Histochem J. 1997 Apr;29(4):279-86 - PubMed
  27. Circulation. 2009 May 26;119(20):2679-85 - PubMed
  28. Acta Diabetol. 2011 Mar;48(1):55-9 - PubMed
  29. Diabetologia. 1983 May;24(5):347-50 - PubMed
  30. Diabetes Care. 2006 Nov;29(11):2528-38 - PubMed
  31. N Engl J Med. 2008 Nov 27;359(22):2324-36 - PubMed
  32. Circulation. 2007 Jan 23;115(3):387-97 - PubMed
  33. Diabetes Care. 2006 Feb;29(2):334-9 - PubMed
  34. Circulation. 1992 Nov;86(5):1443-52 - PubMed
  35. J Hypertens. 2002 Nov;20(11):2183-9 - PubMed
  36. Diabet Med. 2001 Mar;18(3):199-205 - PubMed
  37. J Am Coll Cardiol. 2005 Sep 6;46(5):807-14 - PubMed
  38. J Hypertens Suppl. 1990 Dec;8(6):S135-40 - PubMed
  39. Scand J Clin Lab Invest. 2008;68(7):654-9 - PubMed
  40. Diabet Med. 1993 Nov;10(9):820-4 - PubMed
  41. Br Heart J. 1988 Mar;59(3):379-83 - PubMed
  42. Circulation. 2007 Jan 16;115(2):228-35 - PubMed
  43. Circulation. 2006 Jan 3;113(1):30-7 - PubMed
  44. Exp Clin Endocrinol Diabetes. 2004 Nov;112(10):561-5 - PubMed
  45. Diabetes Care. 2010 Oct;33(10):2285-93 - PubMed
  46. Nephrol Dial Transplant. 1997 Dec;12(12):2612-7 - PubMed
  47. J Cardiovasc Comput Tomogr. 2009 Mar-Apr;3(2):122-36 - PubMed
  48. Br J Prev Soc Med. 1977 Mar;31(1):42-8 - PubMed
  49. Am J Cardiol. 2006 Nov 15;98(10):1387-92 - PubMed
  50. Chronobiol Int. 2009 Jul;26(5):942-57 - PubMed
  51. J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):240-5 - PubMed
  52. Radiology. 2003 Sep;228(3):826-33 - PubMed

Substances

MeSH terms

Publication Types